With treatment options such as oral medication kits or compounded GLP-1 injections, plans are personalized to your body, health history, and weight loss goals. Hers' science-backed program ...

Hims & Hers (HIMS) went all-in on weight-loss drugs. It bet big on cheaper, compounded versions of blockbuster GLP-1 treatments like ...

The rapid rise of GLP-1 weight-loss drugs has come with a raucous side show—a wave of copycat drugs unbound by drug patents. The knockoff surge was led by Hims & Hers Health, the telehealth firm that ...

Whether you want to lose weight to feel better or to improve your overall health, there’s a weight loss plan for you. One popular option, Weight Loss by Hers ... 1 injections or oral ...

The company poured millions into marketing$16 million alone on a Super Bowl adand built its growth story around weight loss. But with GLP-1 sales vanishing, Hims is left banking on generic weight ...

Doctor, doctor, give me the news, Hims & Hers Health (HIMS ... Nordisk’s (NVO) GLP-1 medications Ozempic and Wegovy, which are approved to treat diabetes and weight loss, respectively.

Net income climbed to $26.01 million, or 11 cents per share, from $1.25 million ... Hims & Hers CEO Andrew Dudum said on the call. Going forward, the company said its weight loss offerings ...

Hims & Hers ... GLP-1 medications Ozempic and Wegovy. The company was a breakout star within the digital health sector in 2024, in part because of the success of its popular new weight loss ...